Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL514800 (Apremilast, CC-10004, CC10004, Otezla) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
phosphodiesterase 4B/Phosphodiesterase 4B in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL275] [GtoPdb: 1301] [UniProtKB: Q07343] | ||||||||
ChEMBL | Inhibition of human PDE4B using [3H]cAMP as substrate incubated for 5 mins followed by substrate addition and measured after 10 mins by scintillation proximity assay | B | 7.13 | pIC50 | 74 | nM | IC50 | Bioorg Med Chem (2016) 24: 5702-5716 [PMID:27713015] |
ChEMBL | Inhibition of recombinant human PDE4B2 expressed in African green monkey COS7 cells using cAMP as substrate | B | 7.52 | pIC50 | 30 | nM | IC50 | J Med Chem (2018) 61: 2472-2489 [PMID:29502405] |
ChEMBL | Inhibition of PDE4B (unknown origin) | B | 7.57 | pIC50 | 27 | nM | IC50 | Eur J Med Chem (2019) 174: 198-215 [PMID:31035240] |
GtoPdb | Potency against recombinant human PDE4B1 and B2 isoforms in a TR-FRET assay. | - | 7.57 | pIC50 | 27 | nM | IC50 | Cell Signal (2014) 26: 2016-29 [PMID:24882690] |
phosphodiesterase 4D/Phosphodiesterase 4D in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL288] [GtoPdb: 1303] [UniProtKB: Q08499] | ||||||||
ChEMBL | Inhibition of PDE4D2 (unknown origin) | B | 6.27 | pIC50 | 540 | nM | IC50 | J Med Chem (2020) 63: 3370-3380 [PMID:32115956] |
ChEMBL | Inhibition of PDE4D (unknown origin) using cAMP as substrate | B | 7.13 | pIC50 | 74 | nM | IC50 | J Med Chem (2019) 62: 5579-5593 [PMID:31099559] |
ChEMBL | Inhibition of human PDE4D catalytic domain (86 to 413 residues) expressed in Escherichia coli BL21 (DE3) cells using [3H]cAMP as substrate measured after 30 mins by scintillation proximity assay | B | 7.32 | pIC50 | 47.6 | nM | IC50 | J Nat Prod (2020) 83: 1229-1237 [PMID:32100544] |
GtoPdb | Potency against recombinant human PDE4D2 isoform in a TR-FRET assay. | - | 7.48 | pIC50 | 33 | nM | IC50 | Cell Signal (2014) 26: 2016-29 [PMID:24882690] |
ChEMBL | Inhibition of PDE4D (unknown origin) | B | 7.48 | pIC50 | 33 | nM | IC50 | Eur J Med Chem (2019) 174: 198-215 [PMID:31035240] |
phosphodiesterase 4A in Human [GtoPdb: 1300] [UniProtKB: P27815] | ||||||||
GtoPdb | Potency against recombinant human PDE4A1A isoform in a TR-FRET assay. | - | 7.85 | pIC50 | 14 | nM | IC50 | Cell Signal (2014) 26: 2016-29 [PMID:24882690] |
phosphodiesterase 4C in Human [GtoPdb: 1302] [UniProtKB: Q08493] | ||||||||
GtoPdb | Potency against recombinant human PDE4C1 isoform in a TR-FRET assay. | - | 6.93 | pIC50 | 118 | nM | IC50 | Cell Signal (2014) 26: 2016-29 [PMID:24882690] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]